Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
2023/03/24
Public Notice for the 2,195-Ton Annual Production Project of Active Pharmaceutical Ingredients (Phase I) by Wanbangde Pharmaceutical Group Co., Ltd.
March blooms with flowers—time to embrace passion and blossom into your finest selves. | @To all the Wanbande goddesses, hurry over and receive this most beautiful wish!
2023/02/27
Industry-Education Integration and School-Enterprise Collaboration | Wanbangde Pharmaceutical Group Successfully Selected for the "2021–2022 Zhejiang Province Industry-Education Integrated Enterprise" List!
2023/01/17
Environmental Announcement for Wanbangde Pharmaceutical Group's Annual Production Project of 2,195 Tons of Active Pharmaceutical Ingredients (including 12 products such as 600 tons/year of lipoic acid)
2023/01/15
Honors | Wanbangde Pharmaceutical Group Named Among Top 500 High-Tech Enterprises in Zhejiang Province for Innovation Capability!
Good News! Wanbangde Pharmaceutical Group has been named to the "Most Promising Growth Enterprise in China's Pharmaceutical Industry" list for the fourth consecutive year!
2022/11/18
Public Notice on the Completion and Commissioning of Environmental Protection Facilities for the 980-Ton Per Year Norfloxacin Technology Upgrade Project (Front-End Supplement) at Wanbangde Pharmaceutical Group Co., Ltd.
2022/11/03
Quality Month | Wanbande Pharmaceutical Group’s 5th Annual QCC Selection Event Concludes Successfully
Create the present, shape the future | The Pharmaceutical Group's 5th "Quality Month" Event and Creative Quality Show Contest Conclude Successfully
Striving forward with determination and courage | Phase-wise summary of the Pharmaceutical Group's 6S management initiative released!
2022/10/15
Brand Powerhouse | The 2022 China Brand Value Evaluation Report Reveals: Wanbangde Pharmaceutical Group Named on the List of Independently Innovative Brands!
2022/10/12
Honors | Wanbangde Group Co., Ltd. Receives Zhejiang Province’s “Red Cross Benevolence Contribution Award”
Honors | Wanbangde Group Continues to Rank Among China's Top 500 Private Manufacturing Enterprises in 2022
United in purpose and rhythm, moving forward with collective strength— A recap of Wanbangde Pharmaceutical Group’s 2022 team-building activities for Quality, Administration, and HR.
Quality Month | Wanbangde Pharmaceutical Group Successfully Holds 2022 "Quality Month" Kickoff Event
